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believed to affect as many as 17 million people worldwide, 12 with 91.1 million individuals at risk for infection. 4 Fasciola hepatica infects humans on all continents (except Antarctica), having the widest latitudinal, longitudinal, and altitudinal distribution of the food-borne trematodiases (FBT) and other parasitic and vector-borne diseases. 13 In contrast, Fg infection is more geographically constricted, occurring in the tropical regions of Africa, the Middle East, and Asia, where infection due to either species may occur. 5 Contrary to early thinking, prevalence of veterinary disease is not predictive of prevalence of human disease in endemic regions. 13 Prior to 1980, fascioliasis was thought to be a zoonosis of only mild, sporadic, or local importance. In the past 20 years however, a more complete understanding of disease epidemiology has emerged. 14 Mas-Coma and colleagues have proposed an epidemiologically useful classification, based on more recent studies, to better understand fascioliasis. 14 Imported cases are those acquired in an endemic area but diagnosed in a region lacking indigenous fascioliasis, even in animals. Imported fascioliasis in the returned traveler exemplifies this situation.
Autochthonous, isolated, non-constant cases occur in areas where animal and human infections are recognized but are sporadic and not endemic. Indigenous cases resulting from ingestion of contaminated watercress in Hawaii are examples.
Endemic regions can be described as hypoendemic, mesoendemic, or hyperendemic, depending on whether coprological diagnosis on inhabitants reveals a prevalence of less than 1%, 1%-10%, or greater than 10%, respectively. Typically, in hypoendemic regions sanitation usually involves latrines or sewage disposal systems and outdoor defecation is unusual. In contrast, in hyperendemic areas, indiscriminate defecation is common, as latrines and waste management systems are absent. Human egg shedding contributes significantly to disease transmission in this circumstance.
Epidemic outbreaks can be characterized as occurring in areas where fascioliasis is endemic in animals but not humans and in areas where the disease is endemic in both animals and humans.
Areas of the world with the highest prevalence of fascioliasis include the highlands of Bolivia (the Bolivian Altiplano has the highest prevalence in the world 14 ) , Ecuador, and Peru; Cuba; Portugal and Spain; Turkey; the Nile Delta of Egypt and elsewhere in Africa; the northern regions of the Islamic Republic of Iran and elsewhere in Asia; and central Vietnam. 7 Imported fascioliasis in the United States (and other developed countries) has been extensively reviewed. 8, [15] [16] [17] [18] [19] Twenty-three cases of imported fascioliasis diagnosed in the United States have been summarized. 19 A handful of indigenous cases, primarily associated with consumption of contaminated watercress, have been identified in Hawaii, California, and Florida, as well. 19 Most cases seen in the United States will involve immigrants from endemic areas and returned travelers infected while visiting such regions ( Figure 1) .
The life cycle of Fasciola is shown in Figure 2 . 20 Understanding the interaction between the parasite and its accidental human host at a molecular pathophysiological level is resulting from recent investigations. 21 Unlike the other FBT, in which consumption of raw or undercooked seafood is necessary for infection, humans most often become accidental hosts of Fasciola when they ingest aquatic vegetation on which the metacercariae have encysted. Implicated plants include (most commonly) watercress, 6 water morning glory (pak boong), 8 other aquatic plants, salads in endemic areas such as the highlands of South America, 22 and alfalfa juice (which is used as a medicinal tonic in Peru). 23 Another source of infection is drinking water contaminated with free-living (non-encysted) metacercariae. The least common mode of transmission is the consumption of raw or undercooked liver infected with immature or adult forms of the worm.
Clinical Manifestations
Given that more than half of cases are subclinical (asymptomatic), 6 human infection can be classified as acute or chronic based upon clinical manifestations and laboratory findings. These 2 classifications have been further subdivided into 6 phases ( Table 1) . 7 In a review of 173 cases, 15 clinical manifestations included abdominal pain in 125 (72%), fever in 99 (57%), constitutional symptoms in 76 (44%), urticaria in 22 (13%), itching in 17 (10%), respiratory symptoms in 14 (8%), headache in 8 (5%), and cardiac symptoms in 2 (1%). Laboratory and other evaluations revealed eosinophilia (>500/mm 3 ) in 96%, leukocytosis (>10,000/mm 3 ) in 64%, eggs in feces in 40%, and positive computed tomography in 70%. In chronic infection beyond the latent phase, clinical manifestations are those of the complications of fascioliasis, namely ascending cholangitis, cholelithiasis, cholecystitis, pancreatitis, biliary cirrhosis, and hepatic fibrosis. Unlike other FBT, fascioliasis has not yet been associated with the development of cholangiocarcinoma. 24 Typical fascioliasis results from the migration of immature worms through Glisson's capsule and the liver parenchyma en route to the bile ducts, where they mature and take up permanent residence. Occasionally the metacercariae reach ectopic destinations, resulting in a cutaneous or visceral larva migrans picture reminiscent of strongyloidiasis, taeniasis, or gnathostomiasis. [25] [26] [27] The clinical findings with ectopic migration will depend upon the organs or tissues invaded.
Diagnostic Approach to Fascioliasis
Clearly, the appropriate diagnostic approach to the patient with possible fascioliasis depends first and foremost on a high index of suspicion, as well as the stage of the infection and the resources and expertise available.
Laboratory Evaluation
Eosinophilia, leukocytosis, and elevated inflammatory markers are common in acute infections ( Table 1) ; anemia and/or elevated serum hepatic transaminases, bilirubin, or alkaline phosphatase are only occasionally transiently present during chronic infection. Within 2 to 4 weeks of becoming infected, a Fasciola-specific serologic response ensues, allowing confirmation of infection 5 to 7 weeks before eggs appear in Figure 3_Reference Laboratory for Fasciola Serology Falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and enzyme-linked immunoelectrotransfer blot (EITB) 28, 29 Dr. 41 based on sizes of eggs in human fecal specimens. 42, 4 the feces. In the United States, serology is not commercially available and the Centers for Disease Control and Prevention refers Fasciola serology requests to a reference laboratory ( Figure 3) . 28, 29 Despite some cross-reactivity of the Falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) with serum from those with schistosomiasis (which generally can be clarified by the clinical scenario), the sensitivity of the test is reported to be 95%. 30 The sensitivity of the confirmatory enzyme-linked immunoelectrotransfer blot (EITB), using 12-, 17-, and 63-kiloDalton antigens, is reported to be 100%. 30 Positive serology can also be used to document infection in the chronic phase, when egg release may be intermittent or absent. Serology should revert to negative within a year of successful treatment. A variety of serodiagnostic methods have been described, [31] [32] [33] [34] [35] [36] [37] [38] [39] including 2 commercially available testing kits available in Europe and elsewhere. 38, 39 An ELISA assay to detect Fh coproantigens in preserved human stool samples has been described, 40 but the standard fecal study for the diagnosis of fascioliasis is the identification of eggs in the stool. In hyperendemic settings, children may shed thousands of eggs per gram of feces. 3 A tabular comparison ( Table 2) [41] [42] [43] and Figure 4 41 illustrate the similarities and differences among the eggs of most human trematodes. Figure 5 shows unstained wet mounts of Fh eggs. 20 Infection due to Fh and Fg classically has been differentiated by the geographic distribution of the organisms, when the 2 do not overlap. In regions endemic for both, however, it was thought that the size of the eggs shed in the feces could differentiate the 2 kinds. In livestock, the eggs of Fg are significantly larger than those shed by Fh, and this was thought to be true for human shedding as well. Recent work corrects this teaching, demonstrating that Fh eggs shed by humans are larger than those shed by livestock, while Fg eggs shed by humans are smaller than those shed by livestock, with considerable overlap. Thus, one cannot speciate human fascioliasis on the basis of the size of the eggs shed in the stool. 44 Adult worms are found in the biliary tract, while migrating larvae can be found anywhere in the human host (most often in the skin or other sites of ectopic migration). Rarely, a worm will be retrieved from the patient (for example, by endoscopic retrograde cholangiopancreatography [ERCP]). 45 A comparison among the adult visceral trematodes of humans is demonstrated in Figure 6 . 41 Unstained, formalin-fixed and carmine-stained adult Fh worms are shown in Figure 7 . 20 An immunofluorescent antibody test with 90% sensitivity and specificity can be performed on worm sections, if the diagnosis is in doubt (Figure 3 ).
Diagnostic Imaging
In the appropriate clinical context, imaging studies can be very useful to confirm the diagnosis of fascioliasis. [46] [47] [48] Typical findings include subcapsular hemorrhage; parenchymal nodular, ill-defined lesions, which may coalesce into tortuous or tubular tracks; filling defects in the biliary tract; and subcapsular, peribiliary, or periportal indistinct nodules and abscesses. Ultrasound, computed tomography, magnetic resonance imaging, and, to a lesser extent, nuclear medicine scanning all have a role. Endoscopic retrograde cholangiopancreatography and magnetic resonance cholangiopancreatography (MRCP) have been found to be useful in chronic disease when the adult worms occupy the biliary tree.
Histopathology
Rarely, a biopsy is performed, and a tissue diagnosis is made, most often when the diagnosis has not been considered. With ERCP removal of a worm, diagnosis can be confirmed as above. In ectopic fascioliasis, removal of the migrating metacercariae is diagnostic, as well. A liver biopsy typically reveals necrosis, acute and chronic inflammatory changes, debris, and occasionally fragments of migrating larvae.
Treatment of Fascioliasis
Unlike other helminth infections, fascioliasis responds very poorly to treatment with albendazole or praziquantel. The reason(s) for this lack of treatment effectiveness are not understood. Currently, the drug of choice is triclabendazole, [49] [50] [51] [52] which is not commercially available in the United States. It may be ordered from Victoria Pharmacy, Zurich, Switzerland. 53 Outside of the United States, it is available from the manufacturer, Novartis (Basel, Switzerland), for both treatment of individual cases and for mass administration as part of
Specific Features and Variations
Lateral spine. Found in feces; in rare cases, in urine also. Eggs are discharged at irregular intervals and may not be found in every stool specimen. They are rare in chronic stages of infection. Found in feces. Often coated with debris and may be overlooked.
Terminal spine. Found in urine, occasionally in feces. Egg often covered with debris. Terminal spine long, slender with bent tip. Resembles S. haematobium egg except it is longer, is thinner, and has a longer spine. Found in feces. May have debris adhering to shell. Found in feces. Closely resembles S. japonicum egg except it is smaller. May be coated with debris.
Small size, operculum and "knob" on posterior end. Shell often is covered by adhering debris.
Lacks prominent shoulders characteristic of Clonorchis and has more tapered end.
Resembles Clonorchis egg but with less distinct "shoulders." Operculum is broader than in Clonorchis. Resembles Clonorchis and Heterophyes eggs. Shell is slightly thinner than Heterophyes. Operculum is broader than Clonorchis.
Found in sputum, occasionally in feces. Resembles egg of D. latum but is larger, slightly asymmetrical, and the operculum is smaller and flatter. The widest part of the Paragonimus egg is usually anterior to the center; in a D. latum, the widest area is around the center. Large size. Broadly oval eggs. national control strategies. 7 The dose is 10 mg/kg by mouth once or twice, given with food. Alternatives include bithionol, available from the Centers for Disease Control and Prevention Drug Service, Atlanta, GA. The dose is 30-50 mg/kg by mouth on alternate days for 10-15 doses. 53 More recently, studies have suggested that nitazoxanide may be an effective alternative as well. 53, 54 The dose is 500 mg by mouth twice daily for 7 days for adults. The dose is reduced to 100 mg twice daily for children aged 1-3 years and 200 mg twice daily for children aged 4-11 years. Those 12 years and above receive the adult dose. 53 There may be a role for treatment with artesunate in certain settings, based upon a pilot study. 55 As with all such diseases, prevention of infection by provision of clean water and safe food, control of sewage and waste, and healthy travel hygiene is preferable to treatment of established infection.
Conclusion
Fascioliasis is a disease rarely encountered in the United States. As a result, correct diagnosis is often delayed because the infection is not considered. As the laboratory plays an important role in confirming the diagnosis, it is important to consider the disease in a patient with risk factors and proceed with appropriate testing and treatment. 
